Published by Josh White on 3rd March 2021
(Sharecast News) - Commercial biotechnology company Allergy Therapeutics reported a 7% improvement in its revenue in actual terms in its interim results on Wednesday, and 5% growth at constant rate, to £54.0m.
URL: http://www.digitallook.com/dl/news/story/31683450/...